Viewing Study NCT03127605


Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2026-03-01 @ 3:23 PM
Study NCT ID: NCT03127605
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2020-05-18
First Post: 2017-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Inotuzumab Ozogamicin - PF-05208773
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Design Module Arms Interventions Module Eligibility Module